The largest measles outbreak, including 38 modified measles and 22 typical measles cases, Yamagata, Japan, 2017 in its elimination era

  • Komabayashi Kenichi
    Department of Microbiology, Yamagata Prefectural Institute of Public Health
  • Seto Junji
    Department of Microbiology, Yamagata Prefectural Institute of Public Health
  • Tanaka Shizuka
    Department of Microbiology, Yamagata Prefectural Institute of Public Health
  • Suzuki Yu
    Department of Microbiology, Yamagata Prefectural Institute of Public Health
  • Ikeda Tatsuya
    Department of Microbiology, Yamagata Prefectural Institute of Public Health
  • Onuki Noriko
    Yamagata Prefecture Division of Health and Welfare Planning
  • Yamada Keiko
    Okitama Public Health Center
  • Ahiko Tadayuki
    Department of Microbiology, Yamagata Prefectural Institute of Public Health Murayama Public Health Center
  • Ishikawa Hitoshi
    Shonai Public Health Center
  • Mizuta Katsumi
    Department of Microbiology, Yamagata Prefectural Institute of Public Health

書誌事項

タイトル別名
  • The Largest Measles Outbreak, Including 38 Modified Measles and 22 Typical Measles Cases in Its Elimination Era in Yamagata, Japan, 2017

この論文をさがす

抄録

<p>The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20–39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9–25 transmissions. These patients were 22–31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20–39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.</p>

収録刊行物

被引用文献 (6)*注記

もっと見る

参考文献 (14)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ